Libby Research Partnership Reunion and Planning Meeting
May 2019: Dr Emmett, Director of the Community Engagement Core, was an invited attendee at this meeting held at Libby MT on May 17 and 18, 2019. Libby is the site of extensive asbestos contamination and of the first Declared Public Health Emergency in the United States.
Asbestos Disease Awareness Organization at Penn Medicine Occupational Medicine Residents and SRP Trainees
May, 10 2019: Marilyn Amento, an Ambler resident who lost her husband to Mesothelioma, who also works with the Asbestos Disease Awareness Organization (ADAO), gave a presentation to the University of Pennsylvania School of Medicine Occupational Medicine Residents and SRP trainees.
The Stunning Truth About Asbestos Use in the US (A PBS NewsHour Video)
Asbestos is no longer ubiquitous in building materials, and since it's proven to cause cancer, many Americans likely assumed the substance had been banned entirely. But not only is asbestos a naturally occurring mineral, it is also still used to make some household products. Science correspondent Miles O’Brien reports on "broken" U.S. regulation and why we continue to import the carcinogen.
Synthetic flaxseed derivative helps heart function in septic mice
Project Leader of Project 5-Dr. Melpo Christofidou-Solomidou recently published that synthetic flaxseed derivative helps heart function in septic mice
" . . . Our study has clearly shown that serum HMGB1 is not a biomarker of systemic disease . . ."
Could Statins Ease Deadly Heart Condition in Rare Neuromuscular Disease?
Penn study shows that cholesterol drug may help Friedreich’s ataxia patients
Penn Superfund Research Program (SRP) Investigator, Anil Vachani, MD, FCCP, Receives Distinguished CHEST Educator (DCE) Designation
CHEST 2017 may be over, but congratulations are still in order for Distinguished CHEST Educator Class of 2017 The American College of Chest Physicians is pleased to announce the inaugural class of Distinguished CHEST Educators.
Director of the Penn SRP receives the Founders Award during a Symposium in his honor on August 20, 2017 at the ACS National Meeting.
Ian A. Blair has won the 2017 Founders Award from the Division of Chemical Toxicology of the American Chemical Society. Dr. Blair has made outstanding contributions to the field of Chemical Toxicology. He has pioneered the use of mass spectrometry to identify biomarkers for carcinogenesis, cardiovascular disease, and neurodegeneration.
The Hill Blog: Reagan's Superfund research must get back to Bush II funding levels
Congress should continue to support President Reagan's Superfund Research Program (SRP) in the fiscal 2017 and 2018 Interior, Environment and Related Agencies Appropriations bills and restore SRP funding . . . [read more]
Research Features: Protect and serve: community-driven superfund science takes aim at asbestos exposure
As a direct response to local community concerns, Dr Ian A Blair and colleagues at the Penn SRP Center are using federal funds to study asbestos exposure pathways that lead to asbestos-related diseases. Dr Blair hopes to identify biomarkers of asbestos exposure with the aim of assessing an individual’s risks of developing asbestos-related diseases . . .
Penn Superfund Research Center Studies Asbestos from all Angles
Penn's Superfund Research & Training Program (SRP) studies asbestos from all angles. University of Pennsylvania program addresses aspects from environmental containment to health effects.
Ads in which a lawyer talks about compensation for asbestos exposure and mesothelioma have been a television mainstay in the U.S. for a long time. Watching those, one might assume that the science of asbestos—how it’s formed, how it’s transported in the environment, and how it causes lung cancers—is a closed book. It turns out, however, there’s still lots to learn about the long, thin fibrous material.
